Monica Astolfi

Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

Paolo Corradini, Claudia Voena, Corrado Tarella et al. · Journal of Clinical Oncology · 1999 · 242 citations

Medicine, Hematology, Oncology +16

Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

Paolo Corradini, Monica Astolfi, C Cherasco et al. · Blood · 1997 · 163 citations · Full text

Medicine, Hematology, Oncology +17

High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting

Paolo Corradini, Claudia Voena, Monica Astolfi et al. · Blood · 1995 · 137 citations · Full text

Medicine, Hematology, Oncology +17

Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes

Paolo Corradini, Marco Ladetto, Francesco Zallio et al. · Journal of Clinical Oncology · 2004 · 126 citations

Medicine, Hematology, Oncology +17

Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.

Paolo Corradini, Giorgio Inghirami, Monica Astolfi et al. · PubMed · 1994 · 112 citations

Medicine, Genetics, Oncology +14